Podcast

Vikas Majithia, MD, on New and Existing Treatments for AxSpA

08/19/2022

Dr Majithia discusses the options for treating axial spondyloarthritis, including the newest approved agent, upadacitinib.

Vikas Majithia, MD, is chair of the Division of Rheumatology and a senior associate consultant in the Department of Medicine at Mayo Clinic-Florida in Jacksonville.

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Conference Coverage

Lihi Eder, MD, on Metabolic Disorders and Diet Among Patients With Psoriatic Disease

08/14/2023

Priyam Vora ;

Dr Eder, from the University of Toronto, presented a poster at ACR Convergence on research that sheds light into how metabolic disorders and abnormal dietary patterns affect psoriatic arthritis disease activity.

Dr Eder, from the University of...

08/14/2023

Rheumatology & Arthritis

News

Comparing Exercise Therapies For Knee Osteoarthritis

02/01/2023

Priyam Vora ;

Researchers compared high- versus low-dose exercise therapies for patients with knee osteoarthritis to understand the optimal exercise dose. Read to learn about the results.

Researchers compared high-...

02/01/2023

Rheumatology & Arthritis

News

Simulation Model Projects Outcomes for ANCA-Vasculitis Retreatment Strategies

04/04/2023

The AAV-Sim model shows potential in helping guide management of and research into antineutrophil cytoplasmic antibody-associated vasculitis.

The AAV-Sim model shows...

04/04/2023

Rheumatology & Arthritis

News

Ranking Patient-Reported Outcome Measures for Patients With PsA

06/21/2023

Priyam Vora ;

Investigators sought to establish the responsiveness to therapy and minimum clinically important improvement for patient-reported outcome measures in psoriatic arthritis.

Investigators sought to...

06/21/2023

Rheumatology & Arthritis

Podcast

Matthew Baker, MD, on Interstitial Lung Disease Among Patients With RA Treated with DMARDs

08/22/2023

Dr Baker reviews the findings of his recent research into the association of interstitial lung disease among patients with rheumatoid arthritis who have been treated with both biologic and targeted disease-modifying antirheumatic drugs.

Dr Baker reviews the findings of...

08/22/2023

Rheumatology & Arthritis

Vikas Majithia, MD, on New and Existing Treatments for AxSpA

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products